Delivery Order SPE2DR25D3103-SPE2DR26F9Z79
Award Date 1/22/26
Potential Completion Date 1/23/26
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Thrombin-JMI 5,000 unit vials. This competitively awarded, non-set-aside contract carries a ceiling value of $7,615.26 under a firm fixed-price delivery order arrangement, with an ultimate completion date of September 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Thrombin-JMI 5,000 Units Vials on April 23, 2025, with a ceiling value of $1,334.80. This competitively awarded, firm fixed price delivery order is scheduled for completion by April 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract involves no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency awarded a delivery order valued at $1,592.70 to AmerisourceBergen Drug Corp for 20,000 unit vials of Thrombin-JMI, a hemostatic agent used in surgical and medical applications. The award, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, is a firm fixed-price contract with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Thrombin-JMI 20,000 unit vials valued at $1,550.51. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Thrombin-JMI 5,000 Units Vials, a pharmaceutical product used in surgical hemostasis and wound management. This firm fixed-price delivery order has a ceiling value of $1,524.48 and an ultimate completion date of January 23, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Thrombin-JMI 5,000 Units Vials with a ceiling value of $1,451.48. This firm fixed price delivery order, which represents a child contract under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by November 28, 2025. The award was not designated as a set-aside contract,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,150.20 to AmerisourceBergen Drug Corp for 5,000 units of Thrombin-JMI vials. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on December 30, 2025, with an ultimate completion date of December 31, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $3,195 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 5,000 units of Thrombin-JMI vials. This contract, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a small-value pharmaceutical procurement to support federal medical supply requirements. The award was made through open competition with no set-aside designation, leveraging AmerisourceBergen's established position as a critical vendor...
- The Defense Logistics Agency awarded a $323,700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 5,000 vials of Thrombin-JMI. The prime contractor will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by August 17, 2023 in support of the Department of Defense's medical supply needs. No major subcontractors or set aside designations were indicated. This delivery order was issued against an existing DLA pharmaceuticals contract vehicle to...
- The Defense Logistics Agency awarded a $274,820 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20,000 unit vials of Thrombin-JMI. As the prime contractor, Amerisourcebergen will deliver the medical supplies to a facility in Conshohocken, Pennsylvania by July 6, 2023 in support of the Department of Defense's ongoing procurement programs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA contract vehicle to...